Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study

Koji Kato; Yoshihiro Inamoto; Toshiro Kawakita; Yasushi Onishi; Ken Ichi Matsuoka; Soichi Shiratori; Kazuhiro Ikegame; Nobuhiro Hiramoto; Masako Toyosaki; Yuta Katayama; Yuhki Koga; Shun Murayama; Yuji Sasagawa; Mami Shindo; Takanori Teshima; Kiyohiko Hatake; Yoshinobu Maeda

doi:10.1038/s41409-025-02775-z

Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study

Koji Kato
, Yoshihiro Inamoto
, Toshiro Kawakita
, Yasushi Onishi
, Ken Ichi Matsuoka
, Soichi Shiratori
, Kazuhiro Ikegame
, Nobuhiro Hiramoto
, Masako Toyosaki
, Yuta Katayama
, Yuhki Koga
, Shun Murayama
, Yuji Sasagawa
, Mami Shindo
, Takanori Teshima
, Kiyohiko Hatake
, Yoshinobu Maeda

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	Bone Marrow Transplantation
DOIs	https://doi.org/10.1038/s41409-025-02775-z
Publication status	Accepted/In press - 2025
Externally published	Yes

All Science Journal Classification (ASJC) codes

Hematology
Transplantation

Access to Document

10.1038/s41409-025-02775-z

Cite this

Kato, K., Inamoto, Y., Kawakita, T., Onishi, Y., Matsuoka, K. I., Shiratori, S., Ikegame, K., Hiramoto, N., Toyosaki, M., Katayama, Y., Koga, Y., Murayama, S., Sasagawa, Y., Shindo, M., Teshima, T., Hatake, K., & Maeda, Y. (Accepted/In press). Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-025-02775-z

@article{d31cdf67e78a443383a3aa494b4cb740,

title = "Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study",

author = "Koji Kato and Yoshihiro Inamoto and Toshiro Kawakita and Yasushi Onishi and Matsuoka, \{Ken Ichi\} and Soichi Shiratori and Kazuhiro Ikegame and Nobuhiro Hiramoto and Masako Toyosaki and Yuta Katayama and Yuhki Koga and Shun Murayama and Yuji Sasagawa and Mami Shindo and Takanori Teshima and Kiyohiko Hatake and Yoshinobu Maeda",

year = "2025",

doi = "10.1038/s41409-025-02775-z",

language = "English",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer Nature",

}

Kato, K, Inamoto, Y, Kawakita, T, Onishi, Y, Matsuoka, KI, Shiratori, S, Ikegame, K, Hiramoto, N, Toyosaki, M, Katayama, Y, Koga, Y, Murayama, S, Sasagawa, Y, Shindo, M, Teshima, T, Hatake, K & Maeda, Y 2025, 'Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study', Bone Marrow Transplantation. https://doi.org/10.1038/s41409-025-02775-z

TY - JOUR

T1 - Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD

T2 - clinical outcomes from a Japanese study

AU - Kato, Koji

AU - Inamoto, Yoshihiro

AU - Kawakita, Toshiro

AU - Onishi, Yasushi

AU - Matsuoka, Ken Ichi

AU - Shiratori, Soichi

AU - Ikegame, Kazuhiro

AU - Hiramoto, Nobuhiro

AU - Toyosaki, Masako

AU - Katayama, Yuta

AU - Koga, Yuhki

AU - Murayama, Shun

AU - Sasagawa, Yuji

AU - Shindo, Mami

AU - Teshima, Takanori

AU - Hatake, Kiyohiko

AU - Maeda, Yoshinobu

PY - 2025

Y1 - 2025

UR - https://www.scopus.com/pages/publications/105023075440

UR - https://www.scopus.com/pages/publications/105023075440#tab=citedBy

U2 - 10.1038/s41409-025-02775-z

DO - 10.1038/s41409-025-02775-z

M3 - Letter

AN - SCOPUS:105023075440

SN - 0268-3369

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

ER -

Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this